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We quantiﬁed the mRNA expression of all 22 ﬁbroblast growth factor family members (FGF) and their four receptors
(FGFR) in adult mouse full-thickness skin at various stages of the hair growth cycle. We found that in addition to
mRNA encoding FGF previously identiﬁed in skin (FGF1, 2, 5, 7, 10, 13, and 22), FGF18 mRNA was also strongly
expressed. Expression of these FGF varied throughout hair growth cycle: mRNA expression of FGF18 and 13
peaked at telogen; FGF7 and 10 at anagen V; and FGF5 and 22 at anagen VI. In situ hybridization revealed that
FGF18 mRNA is mainly expressed in the anagen inner root sheath and telogen bulge of hair follicles. In culture,
FGF18 stimulated DNA synthesis in human dermal ﬁbroblasts, dermal papilla cells, epidermal keratinocytes and
vascular endothelial cells. When FGF18 was administered subcutaneously to mice in a uniform telogen state,
anagen hair growth was observed. Our ﬁndings suggest that FGF18 is important for the regulation of hair growth
and the maintenance of skin in adult mice.
Key words: dermis/fibroblast growth factor/hair growth/receptor
J Invest Dermatol 124:877 –885, 2005
A variety of polypeptide growth factors, including various
members of the fibroblast growth factor (FGF) family, are
expressed in skin. In both mice and humans, FGF are en-
coded by twenty-two distinct genes (Ornitz and Itoh, 2001),
whereas four genes encode transmembrane FGF receptor
(FGFR) tyrosine kinases (Jaye et al, 1992). Among them,
FGF1, 2, 5, 7, 10, 13, and 22, are known to be expressed in
dermal and hair follicular cells and to regulate hair growth
and skin regeneration (du Cros, 1993; du Cros et al, 1993;
Hebert et al, 1994; Danilenko et al, 1995; Marchese et al,
1995; Guo et al, 1996; Petho-Schramm et al, 1996; Rose-
nquist and Martin, 1996; Mitsui et al, 1997; Ortega et al,
1998; Suzuki et al, 1998, 2000; Nakatake et al, 2001; Stenn
and Paus, 2001; Beyer et al, 2003; Kawano et al, 2004). For
instance, earlier experiments revealed the crucial role
played by FGF5 in regulating the onset of catagen during
the mouse hair cycle; that Fgf5 translates into two proteins
(FGF5 and FGF5S) through generation of alternatively
spliced mRNA (Ozawa et al, 1998); and that FGF5S antag-
onizes the catagen-inducing activity of FGF5 (Suzuki et al,
2000). In addition, FGF1, 2, and 7 reportedly promote hair
growth, FGF13 (FHF2) is highly expressed in the bulge re-
gion of hair follicles, and FGF7 and 10 function in concert
via FGFR2 IIIb to stimulate keratinocyte proliferation in nor-
mal and wounded skin (Werner et al, 1994; Marchese et al,
1995; Igarashi et al, 1998; Ohuchi et al, 2000; Kawano et al,
2004). Although these studies suggest the importance of
the concerted activities of FGF in skin, the expression of all
FGF family members in skin have never been systematically
investigated in a single study. We therefore established an
experimental system with which to quantify the expression
of FGF and FGFR mRNA in skin, and comprehensively pro-
filed the dynamic changes in their expression over the
course of the hair growth cycle.
Results
Expression proﬁles of FGF and FGFR family members
in skin at various stages of the hair cycle: abundant
expression of FGF18 mRNA at telogen phase We initially
established an experimental system to quantify the expres-
sion of all Fgf and Fgfr family members (described in Ma-
terials and Methods). The level of expression of each FGF
and FGFR mRNA at the indicated stage in the hair cycle is
shown in Figs 1 and 2, respectively. In addition, the highest
expression levels of all the mRNA and the phases of the hair
cycle at which they occurred are summarized in Table I.
The most strongly expressed genes were Fgf1, 5, 7, 10, 13,
18, and 22 (Fig 1A and Table I). Within this group, the levels
of FGF7 and FGF10 mRNA (or keratinocyte growth factor
(KGF) 1 and KGF 2, respectively) exhibited similar variation
throughout the hair cycle, with the highest expression levels
Abbreviations: FGF, fibroblast growth factor; FGFR, FGF receptor;
HDF, human dermal fibroblasts; HDPC, human hair follicle dermal
papilla cells; HEK, human epidermal keratinocytes; HORSC, hu-
man outer root sheath cells; HUVEC, human umbilical vein end-
othelial cells; PBS, phosphate-buffered saline
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occurring at anagen V (day 8; Fig 1A). The highest levels of
FGF5 and 22 mRNA occurred at anagen VI (day 18: Fig 1A).
Expression of FGF1 mRNA (or acidic FGF) was compara-
tively constant, with maximum levels attained at telogen
(day 0; Fig 1A). At their highest levels, the expression of
some FGF (e.g., FGF7 and 18) was approximately 1  104
copies per ng mRNA. This level of expression was about
60-fold lower than that of b-actin (5.6  105 copies per ng
mRNA at anagen V; Table I), one of the abundant structural
proteins in skin, and was similar to that observed for cyto-
kine tumor necrosis factor-alpha in some cell lines (5  103–
1  104 copies per ng mRNA in U937 and HL60 cells;
Takahashi et al, 2001).
It is noteworthy that even compared to those genes al-
ready known to be expressed in skin (i.e., FGF1, 2, 5, 7,
10, 13, and 22), the expression of FGF18 mRNA, which
peaked during telogen (days 0 and 22), was quite strong
(Fig 1A). Indeed, at most stages, the level of FGF18 ex-
pression was much higher than that of the well-studied
FGF2 (or basic FGF; Fig 1B), and the other FGF as well
(Fig 1A). Moderate levels of FGF3, 6, 9, 11, 20, and 21
mRNA were also expressed (Fig 1A and B), but little or no
expression of FGF4, 8, 14, or 15 mRNA was detected at any
stage of the hair cycle (o100 copies per ng mRNA;
Fig 1B and Table I).
With respect to FGFR, the mRNA encoding both FGFR1
and FGFR3 were abundantly expressed (a maximum of
 47,000 copies per ng mRNA for FGFR1 or  28,000
copies per ng mRNA for FGFR3; Fig 2). The strongest ex-
pression of the former occurred at anagen VI-catagen (days
18 and 20), whereas that of the latter peaked at anagen VI
(day 18; Fig 2). The level of expression of FGFR2 mRNA,
including its IIIb subclass, which is specific for epithelial
cells, was lower than those of either FGFR1 or -3 mRNA
(Fig 2). The level of FGFR4 mRNA was the lowest among the
four receptors (Fig 2).
FGF18 mRNA is expressed in hair follicles This study
addresses the expression and function of FGF18 in skin, so
we initially determined the distribution of its mRNA using
in situ hybridization. We found that at anagen V (day 8),
anagen VI (day 18), and catagen (day 20), FGF18 mRNA
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Figure1
Expression of fibroblast growth factor (FGF) family genes in skin
throughout the hair cycle. (A and B) A portion of the dorsal skin of
male 8-wk-old C3H/HeN mice was depilated during telogen [except
T(0)], and then harvested at various stages of the hair cycle (i.e., at the
indicated times thereafter). Total RNA was extracted and further pu-
rified to mRNA. After reverse transcription using (dT)12–18 as a primer,
the cDNA was amplified with specific primers for the indicated FGF.
With the aid of serial dilutions of standard plasmids, the absolute copy
number for each FGF mRNA was calculated. To verify the specific am-
plification, not only the direct sequencing of the cloned DNA fragment
but also the melting temperature and the size of the amplified fragment
were routinely monitored at the end of each amplification reaction.
Symbols represent means  SE obtained with cDNA from five mice for
each point. Note that the full Y-axis scales differ in A and B. The b-actin
mRNA copy number per ng mRNA in each skin sample was separately
analyzed, and was confirmed to be within the expected range (see
Table I). All quantification experiments were carried out at least twice in
each set of animal experiment to confirm the results. Moreover, the
entire set of animal experiments were performed three times, and the
results obtained were very similar. T, telogen; A, anagen; C, catagen.
The numbers in the parentheses indicate the days after depilation.
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was expressed virtually exclusively in the transient portion
of the inner root sheath cells of the hair follicles, close to the
hair bulb (Fig 3A, C, D; purple signals). At telogen, FGF18
mRNA signals were detected in the bulge region (Fig 3E).
The sense probe produced no signal (Fig 3B). Although
FGF18 mRNA was most abundant at telogen (Fig 1A), we
discovered that mouse telogen skin contains high levels of a
putative, non-specific inhibitor that strongly suppressed
in situ detection of even abundantly expressed mRNA such
as b-actin.1 Consequently, an extended period of time was
required to detect the rather weak FGF18 mRNA signals.
FGF18 induces DNA synthesis in human hair follicle
dermal papilla cells, dermal ﬁbroblasts, epidermal ker-
atinocytes, and vascular endothelial cells To examine
the target cell specificity of FGF18 in skin, we examined its
mitogenic effect on human hair follicle dermal papilla cells
(HDPC), human outer root sheath cells (HORSC), human
dermal fibroblasts (HDF), human epidermal keratinocytes
(HEK), and human umbilical vein endothelial cells (HUVEC).
We found that at relatively high concentrations (100 and
1000 ng per mL) FGF18 induced DNA synthesis in HDPC,
HDF, HEK, and HUVEC (Fig 4A, C, D, and E, respectively),
which is in contrast to FGF7 (KGF), the well-characterized
keratinocyte mitogen that stimulates DNA synthesis in
HORSC and HEK (Fig 4B and D, respectively), but very
weakly in HDPC (Fig 4A), HDF (Fig 4C), and HUVEC (Fig 4E).
FGF18 induces anagen in telogen phase hair follicles
in vivo The in vivo effect of FGF18 on telogen hair follicles
was investigated in C3H/HeN mice. In one set of experi-
ments (Fig 5) carried out, 21 d after subcutaneous admin-
istration of FGF18 protein adsorbed onto Sepharose beads,
four of five mice exhibited hair follicle growth. The exterior
surface of the dorsal skin of one mouse exhibited vigorous
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Figure 2
Expression of fibroblast growth factor receptor (FGFR) family
genes in skin throughout the hair cycle. A skin cDNA was prepared,
amplified with specific primers for the indicated FGFR, and then analy-
zed as described in the legend to Fig 1. Symbols represent mean-
s  SE obtained with cDNA from five mice for each stage. All
quantification experiments were carried out at least twice in each set
of animal experiment to confirm the results. Moreover, the entire set of
animal experiments were performed three times, and the results ob-
tained were very similar. T, telogen; A, anagen; C, catagen. The num-
bers in the parentheses indicate the days after depilation.
Table I. Expression of FGF and FGFR mRNA in adult mouse
skin
Gene
Highest mRNA expression
Copy number (copies
per ng mRNA)
Phase of the
hair cycle at which the
highest mRNA expression
was attained
(day after depilation)
Fgf1 2900  152 Telogen (0)
Fgf2 751  51 Telogen (0)
Fgf3 667  87 Anagen VI (18)
Fgf4 () ()
Fgf5 4307  578 Anagen VI (18)
Fgf6 542  94 Telogen (0)
Fgf7 7467  475 Anagen V (8)
Fgf8 () ()
Fgf9 306  34 Telogen (22)
Fgf10 4389  341 Anagen V (8)
Fgf11 1422  84 Telogen (0)
Fgf12 188  24 Anagen V (8)
Fgf13 4945  87 Telogen (0)
Fgf14 () ()
Fgf15 () ()
Fgf16 171  34 Anagen VI (18)
Fgf17 179  7 Anagen VI (18)
Fgf18 9822  1,875 Telogen (0)
Fgf20 465  50 Telogen (0)
Fgf21 898  113 Anagen VI (18)
Fgf22 2685  307 Anagen VI (18)
Fgf23 () ()
Fgfr1 47,108  3088 Catagen (20)
Fgfr2 10,414  1179 Anagen VI (18)
Fgfr3 28,540  2253 Anagen VI (18)
Fgfr4 1028  214 Catagen (20)
b-actin 562,240  40,910 Anagen V (8)
The absolute mRNA copy number for each FGF (Fgf) and FGF receptor
(Fgfr) gene was determined as described in the text; each mRNA copy
number is indicated with the hair cycle phase at which mRNA expression
was maximal. The values are means  SE of five replicate samples.
(), genes with low copy numbers (o100 copies per ng mRNA); FGF,
fibroblast growth factor; FGFR, FGF receptor.
1Kawano and Imamura, manuscript in preparation.
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hair growth throughout the entire test area, whereas three
others exhibited hair growth and/or pigmentation at various
parts of the test area (photographs not shown). Examination
of the reverse side of the skin revealed extensive growth of
anagen hair follicles in the mice with pigmentation and/or
hair growth (Fig 5A and B, the reverse side of the pigmented
area is shown; black spots indicate anagen hair follicles).
We also noted that the skin was thicker in these areas than
was the skin from control mice (Fig 5C and E), just as nor-
mal skin with physiological anagen hair follicles is thicker.
The skin from one of the five mice that received FGF18
showed no apparent changes, whereas none of the skin
samples from the five control mice exhibited hair growth or
strong pigmentation. Examination of the reverse side of
control skin revealed little or no anagen hair follicles, as is
indicated by their white color (Fig 5D). Finally, these results
were further confirmed by histological examination of skin
sections (Fig 5C and E; representative results are shown).
Anagen follicles were often observed in, but not limited
to, the approximate area of the implanted beads, suggest-
Figure3
Localization of fibroblast growth factor
(FGF)18 mRNA to hair follicles. A por-
tion of the dorsal skin of 8-wk-old C3H/
HeN mice was isolated (E; telogen) or
depilated and isolated after 8 d (A and B;
anagen V), 18 d (C; anagen VI) or 20 d (D;
catagen). The harvested skin samples
were immediately frozen in OCT com-
pound and sliced into 10-mm-thick sec-
tions. In situ hybridization was then
carried out using digoxygenin-labeled an-
tisense riboprobes specific for FGF18 (A,
C, D, and E). As a control, the sense
probe was also prepared and used for
hybridization (B). The bound riboprobe
was detected using anti-digoxygenin an-
tibody conjugated with alkaline-phospha-
tase; the signals were visualized using
BM Purple (arrows; purple signals). Some
sections were counterstained with Kern-
echtrot solution (pink color; right two
panels in A and B and the right panel in
C and D). Scale bars¼ 100 mm.
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ing that FGF18 protein was not tightly bound to the Seph-
arose beads. When a similar set of experiments in which
mice were kept for 24 d was carried out, five of eight mice
that received FGF18 showed apparent induction of anagen
hair follicles, as judged by pigmentation on the reverse side
of the resected skin. By contrast, only two of seven mice
that received phosphate-buffered saline (PBS) did so.
Finally, we carried out another in vivo experiment, en-
tailing examination of larger numbers of mice for a longer
period of time (57 d) after injection of FGF18. In this exper-
iment, all of the FGF18-injected mice showed vigorous hair
growth by the end of the observation period, as did some of
the PBS-injected mice (Fig 6). For comparison, the ratio of
the hairy area to the total test area in each mouse was
compared between the FGF18-and PBS-administrated
mice. Statistical analysis showed this ratio to be signifi-
cantly larger in FGF18-injected than PBS-injected mice
[0.424  0.260 (n¼15) vs 0.174  0.124 (n¼11); po0.01
(ANOVA)].
Discussion
Among the many polypeptide growth factor systems in-
volved in the dynamics of dermal function, the FGF system
appears to play multiple roles in such physiological proc-
esses as wound healing and hair growth. No earlier studies,
however, have presented a comprehensive or quantitative
analysis of Fgf or Fgfr expression in skin and its append-
ages. We have now carried out such a study, and our results
clearly show that a number of Fgf genes are active in mouse
skin and that their expression changes dynamically and in
differing patterns during the hair growth cycle. This sug-
gests that they play distinct roles in the regulation of hair
growth and related events.
FGFR2 IIIb and its ligands, FGF7, 10 and, presumably,
22, comprise an important cell-type-specific system for
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Figure4
Target cell specificity of fibroblast growth factor (FGF)18 protein.
(A) Effects of FGF18 and FGF7 on DNA synthesis in human hair follicle
dermal papilla cells (HDPC). Serum-starved HDPC were stimulated with
the indicated FGF at the indicated concentrations and 5 mg per mL
heparin. After 8 h, [3H]-thymidine was applied to the cells for 18 h, and
the incorporated radioactivity was counted as described in the text. (B)
Effects of FGF18 and FGF7 on DNA synthesis in human hair follicle
outer root sheath cells (HORSC). HORSC were starved for 24 h and
stimulated with the indicated FGF at the indicated concentrations in the
keratinocyte basal medium containing insulin and 5 mg per mL heparin.
After 5 h, [3H]-thymidine was applied to the cells for 21 h, and the
incorporated radioactivity was counted. (C) Effects of FGF18 and FGF7
on DNA synthesis in human dermal fibroblasts (HDF). Serum-starved
HDF were stimulated with the indicated FGF at the indicated concen-
trations without heparin. After 18 h, [3H]-thymidine was applied to the
cells for 8 h, and the incorporated radioactivity was counted. (D) Effects
of FGF18 and FGF7 on DNA synthesis in human epidermal keratin-
ocytes (HEK). HEK were stimulated with the indicated FGF at the in-
dicated concentrations in keratinocyte basal medium containing insulin
and 5 mg per mL heparin. After 20 h, [3H]-thymidine was applied to the
cells for 8 h, and the incorporated radioactivity was counted. (E) Effects
of FGF18 and FGF7 on DNA synthesis in human umbilical vein end-
othelial cells (HUVEC). HUVEC were stimulated with the indicated FGF
at the indicated concentrations in M199 medium containing 15% FBS
and 5 mg per mL heparin. After 19 h, [3H]-thymidine was applied to the
cells for 6 h, and the incorporated radioactivity was counted. Columns
and bars represent means  SE of triplicate samples. Asterisks ( and
þ ) indicate statistical significance (po0.05 and po0.01, respectively)
between FGF-treated and control (0 ng per mL FGF) cells.
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regulating keratinocyte proliferation. Although FGF7 and
FGF10 are expressed in dermal fibroblasts and papilla cells
and stimulate proliferation of keratinocytes, FGF22 is ex-
pressed in epidermal and hair follicle keratinocytes and also
stimulates keratinocyte proliferation (Nakatake et al, 2001;
Beyer et al, 2003). Thus, this FGF system stimulates kera-
tinocyte proliferation via both an epithelial–mesenchymal
interaction and epithelial autocrine/paracrine stimulation.
The present results confirmed that all three of these previ-
ously characterized keratinocyte mitogens are indeed ex-
pressed at high levels in skin. Furthermore, we noted
remarkable variation in their mRNA expression throughout
the hair cycle. It is interesting that both FGF7 and FGF10 are
maximally expressed at anagen V (day 8), when hair grows
vigorously, whereas expression of FGF22, a presumed au-
tocrine keratinocyte growth factor, is strongly expressed at
anagen VI (day 18), when hair follicle length reaches its
maximum. FGF1, a wide-specificity prototype FGF ligand
with the capacity to stimulate keratinocytes, is expressed in
inner root sheath cells and other follicular cells (Kawano
et al, 2004) and appears to induce dermal papilla cells to
secrete growth promoting factors affecting the outer root
sheath cells (Ota et al, 2002). Thus, although FGF1, 7, 10,
and 22 are all capable of inducing cellular proliferation of the
keratinocyte lineage, they differ in their expressing cells,
mode of action, and target populations.
A gene knockout study revealed that FGF5 is responsible
for inducing catagen during the hair cycle, presumably by
inhibiting activation of dermal papilla cells (Ota et al, 2002).
We found that there was little expression of FGF5 mRNA at
telogen (Fig 1A; days 0 and 22), but that the level was 20-
fold higher at anagen VI (day 18), which is consistent with its
ability to induce catagen.
Other FGF also showed variation in their expression that
was tied to hair cycle progression. Among strongly ex-
pressed FGF, FGF13 is expressed in hair follicle bulge cells
and some basal layer keratinocytes (Kawano et al, 2004).
Although its activity related to stem cell function is not yet
understood, the pattern of its mRNA expression observed in
this study suggests a role during telogen.
Figure 5
Anagen-inducing effect of fibroblast growth factor (FGF)18 protein
in mice with telogen stage hair follicles. (A) Reverse side of resected
skin from mice receiving FGF18. Five 50-d-old male C3H/HeN mice
were anesthetized, their dorsal hair was gently cut short, and 1 mg of
recombinant FGF18 protein in 150 mL of Sepharose bead suspension
was injected subcutaneously into the dorsal test area. The mice were
then maintained on standard laboratory diet and water ad libitum. After
21 d, the exterior appearance of the skin of four of five mice showed
pigmentation; among them three also showed hair growth over all or
part of the depilated area (not shown). One mouse apparently did not
respond to FGF18 during that period. The mice were anesthetized and
sacrificed, the dorsal skin was excised at full-thickness, and its reverse
side was photographed. A representative result is shown. (B) Enlarged
photograph of the skin in panel A (squared area). (C) Histology of the
hair follicles from mice administered FGF18. The skin in A was em-
bedded in paraffin, sectioned (4 mm thickness), stained with hem-
atoxylin (blue) and photographed. A representative result is shown. (D)
Reverse side of resected skin from mice receiving phosphate-buffered
saline (PBS). The same procedure described in A was conducted ex-
cept that PBS was used instead of FGF18. A representative result is
shown. (E) Histology of the hair follicles from mice administrated PBS.
The skin in D was processed as in C. A representative result is shown.
Scale bars¼ 100 mm.
Figure6
Induction of hair growth by fibroblast growth factor (FGF)18 pro-
tein in mice with telogen stage hair follicles. Fifteen 56-d-old male
C3H/HeN mice were anesthetized, their dorsal hair was gently cut
short, and 1 mg of recombinant FGF18 protein in 150 mL of Sepharose
bead suspension was injected subcutaneously into the dorsal test area
(n¼15) (A). As a control, another group of mice received phosphate-
buffered saline in bead suspension (n¼11) (B). After 57 d, all of the
mice receiving FGF18 showed vigorous hair growth. The mice were
then anesthetized, sacrificed, and photographed; three representative
mice for each treatment are shown. The ratio of the hairy area to the
total test area in each mouse was measured and analyzed statistically
(results described in the text).
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We showed here for the first time that FGF18 mRNA is
strongly expressed in hair follicles. Our in situ hybridization
showed that FGF18 mRNA was expressed in the bulge re-
gion during telogen, and that the site of expression moves
to the transient portion of the inner root sheath with pro-
gression of hair follicle growth. We also found that FGF18
stimulates DNA synthesis in dermal fibroblasts and papilla
cells, vascular endothelial cells, and also epidermal kera-
tinocytes (Fig 4). This was somewhat unexpected, as
FGF18 is known to activate FGFR2 IIIc and FGFR3 IIIc,
but activity via FGFR2 IIIb, the keratinocyte-specific recep-
tor, has never been reported. Still, one earlier study showed
that administration of recombinant FGF18 to mice induces
proliferation of hepatic parenchymal cells and pancreatic
ductal epithelium (Hu et al, 1998), illustrating FGF18’s ca-
pacity to exert effects on a wide range of cell types.
FGF18 is also reportedly expressed in the developing
brain (Hoshikawa et al, 2002), pancreas (Dichmann et al,
2003), and adipose tissue (Gabrielsson et al, 2002). It also
reportedly stimulates proliferation of osteoblasts and
chondrocytes (Shimoaka et al, 2002), influences lung
morphogenesis (Whitsett et al, 2002) and improves learn-
ing and memory (Cavallaro et al, 2002). FGFR-2 and FGFR-
3 are expressed in hair follicle matrix cells (Widelitz et al,
1997), suggesting that these cells may be the targets of FGF
18 activity. Interestingly, it was recently reported that Fgf18
is a target gene of Wnt/b-catenin (Shimokawa et al, 2003),
which is an essential signaling pathway for skin and hair
formation (Van Mater et al, 2003). FGF18 may thus be an
important modulator of skin and hair formation.
These results prompted us to investigate the activity of
FGF18 on hair growth in vivo. Administration to mice with
dorsal telogen phase hair follicles revealed that FGF18 is
capable of inducing the anagen growth state, which is con-
sistent with its involvement in modulating hair growth. It is
presently unclear whether FGF18 directly promotes the
proliferation of hair follicle keratinocytes or does so indi-
rectly. Given that, in vitro, FGF18 induced DNA synthesis in
HDPC and HUVEC but not HORSC, even at a high con-
centration, it is unlikely that its ability to potently promote
hair growth in vivo involves direct mitogenic activity. In-
stead, the observation that it takes 3 wk or more to induce
hair growth suggests that FGF18 acts indirectly to modulate
the hair growth cycle. FGF18 may induce dermal papilla
cells to secrete growth factors affecting hair follicle cells, or
it may affect blood circulation by acting on vascular end-
othelial cells. On the other hand, FGF18 exerted a mitogenic
effect on dermal fibroblasts (Fig 4) and may be involved in
the growth of adipocytes (Gabrielsson et al, 2002), sug-
gesting that the increased skin mass seen in FGF18-treated
mice may be attributable to a direct effect on those cells.
In sum, the results suggest that by acting on various cell
types under specific sets of conditions, FGF dynamically
regulate dermal system function. Direct administration of
FGF18 and/or modulation of its expression may thus be an
effective approach to stimulating hair growth.
Materials and Methods
Mice and skin sample preparation Throughout this study, all an-
imals received humane care that was in accordance with the
guidelines of National Institute of Advanced Industrial Science and
Technology (AIST). All protocols were approved by the animal ex-
periment committee of AIST Central 6. For hair cycle experiments,
25 seven-wk-old male C3H/HeN mice (Tlr4þ /þ ) were obtained
from Japan SLC (Hamamatsu, Japan) and maintained on a stand-
ard laboratory diet and water ad libitum. After conditioning for
1 wk, five mice were sacrificed, the dorsal hair was cut short, and
skin samples were isolated and examined as the ‘‘day 0 (telogen)’’
sample. In the remaining 20 mice, the anagen phase of the hair
growth cycle was induced by gently depilating the dorsal hair
shafts with gloved fingers, without using wax, tape, or depilatory
chemicals. Then, at selected stages of the hair follicle cycle (Paus,
1999)—i.e., on days 8 (anagen V), 18 (anagen VI), 20 (catagen IV),
and 22 (telogen) after depilation—the mice (n¼ 5 in each group)
were sacrificed, the hair was cut short for days 18, 20, and 22
mice, and full-thickness skin samples (containing epidermis, hair
shafts, hair follicles, sebaceous glands, subcutaneous adipose
tissue, dermal muscles, and blood vessels) were excised from the
depilated area. The harvested skin samples were then processed
for mRNA isolation, in situ hybridization or immunohistochemical
staining. The experiment was carried out three times using essen-
tially the same design to confirm the reproducibility of the results.
For in situ hybridization, the skin samples were immediately
frozen in optimum cutting temperature compound using liquid ni-
trogen. For immunohistochemical staining, the samples were first
fixed for 16–24 h at room temperature in 10% formaldehyde and
then embedded in paraffin using standard procedures (Suzuki et al,
1998).
mRNA preparation and reverse transcription Total RNA was
prepared from skin samples using Isogen (Nippon Gene, Tokyo,
Japan) according to the manufacturer’s instructions, after which
the mRNA was purified from the total RNA using an Oligotex-dT30
Super mRNA purification kit (Takara Bio, Osaka, Japan). Samples
(100 ng) of the purified mRNA were then reverse transcribed in a
total volume of 20 mL using SuperScript II with Oligo (dT)12–18 as
a primer (Gibco BRL, Tokyo, Japan).
Design of PCR primers and the cloning of FGF cDNA Specific
primer sets were designed so that the levels of FGF mRNA could
be quantitatively analyzed using real-time PCR. The specificity of
the primers was mainly ensured by using the whole mouse cDNA
sequence as the background sequence (a new algorithm devel-
oped by Dr Akira Suyama at Tokyo University). The same sets of
primers were also used to clone the respective cDNA fragments
that served as copy number references for quantification. The
primers used for FGF18 amplification were 50-AGACGCGGGCTC-
GAGATGATGTGAGTCGGA-30 (sense) and 50-GCCCTTGATCCG-
GACTTGACTCCCGAAGGT-30 (antisense). The RT mixture was
diluted ten times with dH2O, after which PCR amplification was
carried out using Pfu polymerase according to the manufacturer’s
(Stratagene, La Jolla, California) instructions. Thereafter, aliquots of
the reaction mixture were run on 2.0% agarose gels to confirm
the size of the amplified products. To clone the respective cDNA,
the PCR products were ligated into pCR-Blunt II-TOPO vector (In-
vitrogen, Carlsbad, California), which was then used to transform
Escherichia coli. The nucleotide sequences of the recombinant
plasmids were verified using a BigDye terminator cycle sequencing
kit and an ABI PRISM 310 Genetic Analyzer (Applied Biosystems,
Foster City, California).
Quantiﬁcation of mRNA copy number by real-time PCR Real-
time PCR amplification was carried out in a Light Cycler (Roche
Diagnostics, Basel, Switzerland) using 2 mL of RT product diluted
1:10 as a template. The absolute copy numbers of each FGF was
determined using each respective plasmid DNA as a copy number
reference.2 Cyber Green was used for quantification of the ampli-
2Suzuki M, et al, manuscript in preparation.
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fied DNA. Highly specific primers, as well as optimized annealing
temperatures, elongation time and acquisition temperatures were
employed in the Light Cycler reaction. To further ensure the
specificity of the reaction conditions, at the end of the individual
runs, the melting temperature (Tm) of the amplified products was
measured to confirm its homogeneity. After the quantification pro-
cedure, the products were resolved by 2.0% agarose gel elect-
rophoresis to confirm that the reaction had amplified the correct
DNA fragments of known size.
For the evaluation of the mRNA, we included serially diluted
DNA samples with the target cDNA sequence in the same Light
Cycler run; from those measurements, the absolute copy number
of the mRNA of interest was calculated for the individual samples.
We also evaluated the copy number of the housekeeping gene b-
actin using the same procedures and confirmed that its abundance
was within the expected range.
In situ hybridization The in situ hybridization experiments were
carried out using OCT-embedded frozen tissue sections and dig-
oxygenin-labeled riboprobes essentially as described previously
(Komminoth, 1992). Sense and antisense riboprobes for FGF18
were synthesized using SP6 and T7 RNA polymerases, respec-
tively, in the presence of digoxygenin-dUTP (Roche Applied Sci-
ence, Mannheim, Germany). All possible effort was made to avoid
RNA degradation during the hybridization procedure. The frozen
tissues were cut into 10 mm sections using a Cryostat (Microm,
model HM500OM, Walldorf, Germany), immediately placed on
MAS-coated slide glasses (Matsunami Glass, Tokyo, Japan), dried
at 501C for 1 h, and then stored at 801C with a desiccant. We pre-
viously determined that fixing the skin tissue before freezing was
disadvantageous, as it impaired signal detection and reduced the
flexibility of the tissue sections, leading to their easy detachment
from slide glasses. Before hybridization, the sections were fixed in
4% paraformaldehyde in PBS for 10 min at room temperature and
then washed with PBS for 5 min. Thereafter, the sections were
permeabilized with proteinase K (0.01 mg per mL in 2  10mM Tris-
Hcl, 1mM EDTA, pH) for 5 min at 371C, rinsed with PBS, again fixed
with 4% paraformaldehyde in PBS for 5 min, and washed with PBS
for 5 min. The fixed sections were soaked twice in 0.1% diethyl-
pyro carbonate in PBS for 15 min, rinsed with PBS, then soaked in
5  saline-sodium citrate for 15 min. Finally, hybridization was
carried out for 16–18 h at 451C using 500 ng per mL of heat-
denatured (701C for 10 min) probe in 100 mL of hybridization buffer
consisting of 50% (vol/vol) formamide, 5  SSC, 500 mg per mL
salmon testes DNA, 250 mg per mL tRNA, 5  Denhardt’s solution,
and 1 mM dithiothreitol. After hybridization, the slides were rinsed
with 2  SSC at 451C and then washed twice with 2  SSC for 30
min at 451C and twice with 0.2  SSC for 20 min at 451C. The
bound riboprobe was detected using an anti-digoxygenin antibody
conjugated with alkaline-phosphatase (1:500, Roche Applied
Science). For visualization, a colorimetric reaction with nitro-blue
tetrazolium and 5-bromo-4-chloro-3-indolyl-1-phosphate (NBT/
BCIP) was carried out using BM Purple (Roche Applied Science)
at room temperature in the dark until the purple signals developed
[24 h for day 8 (anagen V) sections, 48 h for days 18 (anagen VI)
and 20 (catagen) sections, and 96 h for day 0 (telogen) sections].
Some sections were further counterstained (pink) with Kernechtrot
Stain solution (Muto Pure Chemicals, Tokyo, Japan).
DNA synthesis assays Cultured primary HDF (from adult fore-
skin; Toyobo, Tokyo, Japan) subcultured in HDF growth medium
[fibroblast basal medium (FBM) with growth supplement; Toyobo]
and cultured primary HDPC (from adult scalp, Toyobo) subcultured
in HDPC growth medium (Toyobo) were used within two passages
for [3H]-thymidine incorporation assays. The cells were trypsinized
and plated to a density of 1  104 cells per well per 0.5 mL in 48-
well (HDF) or 1  104 cells per well per 1 mL in 24-well (HDPC)
collagen-coated plates (Sumilon, Tokyo, Japan) and then main-
tained in the respective growth medium at 371C. The next day, the
growth medium was replaced with FBM containing 0.5% charcoal-
absorbed calf serum (CH-CS) (HDF) or Dulbecco’s Modified Ea-
gle’s Medium (DMEM) containing 0.5% CH-CS (HDPC), after which
the cells were incubated for 48 h (HDF) or 96 h (HDPC) before
stimulation with the indicated concentration of FGF. The recom-
binant FGF18 and FGF7 (KGF) proteins were purchased fromWako
Pure Chemical Industries (Osaka, Japan). After 18 h (HDF) or 8h
(HDPC) in the presence of FGF with 5 mg per mL heparin (HDPC) or
without heparin (HDF), [3H]-thymidine (2 mCi per mL; Moravek Bi-
ochemicals; California) was added to the medium, and the cells
were incubated for an additional 8 h (HDF) or 18 h (HDPC). The
cells were then harvested, and the incorporated radioactivity was
counted.
Cultured primary HEK (from adult facial skin; Toyobo) and pri-
mary HORSC (from adult male scalp) were subcultured in keratin-
ocyte growth medium [keratinocyte basal medium (KBM)-2
supplemented with bovine pituitary extract, insulin, epidermal
growth factor, hydrocortisone, transferrin, epinephrine, and antibi-
otics; Toyobo] and then used within two passages. The cells were
trypsinized and plated to a density of 1  104 cells per well per 0.5
mL in 48-well (HEK) or 1  104 cells per well per 1 mL in 24-well
(HORSC) collagen-coated plates and then maintained in the ker-
atinocyte growth medium at 371C. The next day (HEK) or 4 d later
(HORSC), the growth medium was replaced with KBM-2 medium
containing 8.6  107 M insulin, hydrocortisone, transferring,
epinephrine (HEK) or with KBM-2 medium containing 8.6  107
M insulin (HORC). The HEK were stimulated with the indicated
concentration of FGF with 5 mg per mL heparin. The HORSC were
cultured for 24 h and then stimulated with FGF with 5 mg per mL
heparin. After 20 h (HEK) or 5 h (HORSC) in the presence of FGF,
[3H]-thymidine (2 mCi per mL; Moravek) was added to the medium,
the cells were incubated for an additional 8 h (HEK) or 21 h
(HORSC) and assayed as described above.
Cultured HUVEC were subcultured in M199 medium supple-
mented with 15% FBS, 10 ng per mL FGF1, and 5 mg per mL
heparin (HUVEC growth medium) and were used for 15 passages.
For experimentation, the cells were first trypsinized and plated
to a density of 2  104 cells per well per 1 mL in 24-well collagen-
coated plates and maintained for 1 d in M199 medium
supplemented with 15% FBS at 371C. Thereafter, the cells were
stimulated with the indicated concentration of FGF with 5 mg per
mL heparin. After 19 h in the presence of FGF, [3H]-thymidine (2 mCi
per mL; Moravek) was added to the medium, and the cells
were incubated for an additional 6 h and assayed as described
above.
In vivo analysis of FGF18 activity To characterize the effect of
FGF18 on hair follicles in vivo, we essentially followed the protocol
developed by McElwee et al (2004) to demonstrate the activity of
macrophage stimulating protein. Briefly, 10 mg of recombinant
FGF18 protein in 0.75 mL of PBS were mixed with 0.75 mL (packed
volume) of Sepharose 4B beads and 7.5 mL of C3H/HeN serum and
incubated at 371C for 2 h. The FGF18-treated bead suspension
was used for injection without washing. Control beads were pre-
pared using the same procedure without FGF18. Fifty-d-old male
C3H/HeN mice were then anesthetized, their dorsal hair was gently
cut short with a trimmer, and the FGF18-treated bead suspension
was injected subcutaneously into the test area (150 mL per mouse;
i.e., 1 mg FGF18 per mouse). In some experiments 56-day-old mice
were used. The mice were then maintained for selected numbers of
days on a standard laboratory diet and water ad libitum, after
which they were anesthetized, sacrificed, and photographed using
a digital camera. The full-thickness of the dorsal skin in the test
area was excised and, after its reverse side was photographed, it
was processed for paraffin embedding. The embedded skin sam-
ples were cut into 4 mm sections using a microtome, stained with
hematoxylin (blue) and observed under a microscope. In some
experiments, the ratio of the hairy area versus the total test area
was measured in the images of each mouse using ImageJ image
analysis software (http://rsb.info.nih.gov/ij/) and was processed for
statistical evaluation.
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